Search

Introducing a broad range of innovative and creative qualitative methods, this accessible book shows you how to use them in research project while providing straightforward advice on how to approach every step of the process, from planning and organisation to writing up and disseminating research. It offers: Demonstration of creative methods using both primary or secondary data. Practical guidance on overcoming common hurdles, such as getting ethical clearance and conducting a risk assessment. Encouragement to reflect critically on the processes involved in research. The authors provide a complete toolkit for conducting research in geography, while ensuring the most cutting-edge methods are unintimidating to the reader.

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.